tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
with an average price target of $199.07. This is a potential upside of $26.71 (15.5%) from yesterday's end of day stock price of $172.36.
Reata Pharmaceuticals's activity chart (see below) currently has 181 price targets and 102 ratings on display.
Analysts average stock forecasts to be materialized ratio is 60.02% with an average time for these price targets to be met of 157.71 days.
Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 15-Aug-2023. First documented stock forecast 20-Jun-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$172
$-0.36 (-0.21%)
$145
2 years 3 months 29 days ago
(15-Aug-2023)
9/15 (60%)
$2.87 (1.70%)
158
Hold
$172.5
$0.14 (0.08%)
$120
2 years 4 months 13 days ago
(01-Aug-2023)
14/22 (63.64%)
$6.4 (3.85%)
237
Hold
$172
$-0.36 (-0.21%)
$110
2 years 4 months 13 days ago
(01-Aug-2023)
6/6 (100%)
$5.9 (3.55%)
171
Buy
$172.5
$0.14 (0.08%)
$140
2 years 4 months 13 days ago
(01-Aug-2023)
1/2 (50%)
$6.4 (3.85%)
22
Hold
$173
$0.64 (0.37%)
$85
2 years 4 months 13 days ago
(31-Jul-2023)
8/12 (66.67%)
$7.42 (4.48%)
185
What is RETA (Reata Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on RETA (Reata Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on RETA (Reata Pharmaceuticals)?
Which analyst is the currently most bullish on RETA (Reata Pharmaceuticals)?
Which analyst is the currently most reserved on RETA (Reata Pharmaceuticals)?
